NASDAQ:SRNE
Delisted
Sorrento Therapeutics Stock News
$0.307
+0 (+0%)
At Close: Feb 23, 2023
Dr. Henry Ji to Participate in the CEO Roundtable during WuXi Healthcare Forum 2021 on March 17, 2021
01:00am, Wednesday, 17'th Mar 2021
SAN DIEGO, March 16, 2021 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE), announced today that Dr. Henry Ji, Chairman and CEO, will participate in the following upcoming conference:
Even Below the $10 Mark There Are Way Better Buys Than BioNano Genomics
07:30am, Tuesday, 16'th Mar 2021
The risk-to-reward proposition has recently gotten a lot better for investors considering BNGO stock. Is it a buy for single digits?
The Dip Is an Opportunity in Sorrento Therapeutics Stock
11:36am, Wednesday, 10'th Mar 2021
The pullback in SRNE stock has cleared 40%. Sorrento has too many ways to win for the stock to stay down forever.
Sorrento Developed Socazolimab Enters Late-Stage Lung Cancer Study In China
07:05am, Monday, 08'th Mar 2021
China's regulatory authorities have signed off on Lee's Pharmaceutical Holdings Limited's Phase 3 trial evaluating socazolimab in small-cell lung cancer. Lee Pharma has in-licensed socazolimab from
SAN DIEGO, March 07, 2021 (GLOBE NEWSWIRE) -- China Oncology Focus Limited (COF), an affiliate of Lee's Pharmaceutical Holdings Limited (Lee's Pharm, HKEX: 950) announced that its anti-PD-L1 antibody,
Dr. Henry Ji to Participate in the H.C. Wainwright Virtual GLOBAL LIFE SCIENCES CONFERENCE 2021 Investor Conference
01:06am, Friday, 05'th Mar 2021
SAN DIEGO, March 04, 2021 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento"), announced today that Dr. Henry Ji, Chairman and CEO, will participate in the following upcoming co
I Was Waiting for a Pullback to Invest. Here's What Changed My Mind
07:10am, Thursday, 04'th Mar 2021
The best time to invest is right now.
Why Ovid, KemPharm, Sorrento, Aquestive Are Rallying
10:17am, Wednesday, 03'rd Mar 2021
Ovid Therapeutics Inc. (NASDAQ: OVID), KemPharm Inc (NASDAQ: KMPH), Aquestive Therapeutics Inc (NASDAQ: AQST) and Sorrento Therapeutics, Inc. (NASDAQ: SRNE) were among the health care gainers in Wedne
SAN DIEGO, March 02, 2021 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) announced today that it has received clearance from the FDA for its Investigational New Drug a
SAN DIEGO, Calif., March 01, 2021 (GLOBE NEWSWIRE) -- Sorrento Therapeutics (NASDAQ: SRNE, “Sorrento”) and Scilex Holdings Company (“Scilex”), a majority owned subsidiary of Sorrento, have ent
Sorrento Therapeutics (SRNE) Stock Sinks As Market Gains: What You Should Know
06:56pm, Wednesday, 24'th Feb 2021
Sorrento Therapeutics (SRNE) closed at $10.97 in the latest trading session, marking a -0.32% move from the prior day.
Sorrento Therapeutics (SRNE) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
01:41pm, Monday, 22'nd Feb 2021
Sorrento Therapeutics (SRNE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Week In Review: Yuanxin Raises $465 Million For Online Healthcare Company Miaoshou Doctor
01:56pm, Sunday, 21'st Feb 2021
Week In Review: Yuanxin Raises $465 Million For Online Healthcare Company Miaoshou Doctor
Is Sorrento Therapeutics a Good Coronavirus Stock to Buy?
06:14am, Sunday, 21'st Feb 2021
The biotech certainly has plenty of COVID-19 candidates in the hopper.
Sorrento Therapeutics (SRNE) Dips More Than Broader Markets: What You Should Know
06:57pm, Wednesday, 17'th Feb 2021
In the latest trading session, Sorrento Therapeutics (SRNE) closed at $13.98, marking a -0.71% move from the previous day.
